title: The human leucocyte sodium pump in Cushing's syndrome.
abstract: Because corticosteroids have important effects on sodium homeostasis, we studied leucocyte 22Na efflux in patients with Cushing's syndrome. The ouabain-sensitive 22Na+ efflux rate constant was raised in Cushing's syndrome (mean +/- SD 2.84 +/- 0.32 vs 2.35 +/- 0.53/h, P less than 0.001, n = 15). This efflux rate constant correlated with the urinary free cortisol (rs = 0.61, P less than 0.02), but less significantly with the 0900 h plasma cortisol (rs = 0.46, P less than 0.08). There was no correlation with the supine plasma aldosterone. Intracellular sodium content was significantly lower in Cushing's syndrome (21.1 +/- 4.6 vs 27.8 +/- 9.5 mmol/kg dry weight, P less than 0.01), with a raised intracellular potassium to sodium content ratio (16.1 +/- 3.3 vs 12.9 +/- 3.6, P less than 0.01). After treatment of the Cushing's syndrome by trans-sphenoidal adenomectomy or adrenalectomy, these defects in cellular sodium balance were corrected. Thus, the distribution of sodium between intra- and extracellular fluid may be affected by adrenal corticosteroids via an action on the sodium pump.
authors.affiliation: Radcliffe Infirmary, Oxford, UK.
authors.forename: L L
authors.initials: LL
authors.lastname: Ng
authors.forename: D J
authors.initials: DJ
authors.lastname: Evans
authors.forename: C W
authors.initials: CW
authors.lastname: Burke
mesh_terms: D000328:Adult; D003480:Cushing Syndrome / Q000378:metabolism* / Q000601:surgery; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000652:urine; D007962:Leukocytes / Q000378:metabolism*; D008297:Male; D010042:Ouabain / Q000494:pharmacology; D015221:Potassium Channels / Q000187:drug effects / Q000378:metabolism; D015222:Sodium Channels / Q000187:drug effects / Q000378:metabolism*
chemical_list: D015221:Potassium Channels; D015222:Sodium Channels; D010042:Ouabain; D006854:Hydrocortisone